Table 1.
All patients’ characteristics
| n = 191 | |
|---|---|
| Age (m ± SD) years | 74.4 ± 10.4 (min: 50, max: 104) |
| Male gender | 121 (63.3%) |
| Height (m ± SD) cm | 160.8 ± 9.4 |
| Body Weight (MD, IQR) kg | 60.0, 52.5–69.0 |
| BMI (MD, IQR) kg/m2 | 23.1, 20.7–25.1 |
| MBP (MD, IQR) mmHg | 115, 101–128 |
| Ischemic Stroke | |
| Large-artery Atherosclelosis and Small-vessel Occlusion | n = 102 |
| Large-artery Atherosclelosis (LAA) | n = 52 |
| Small-vessel Occlusion (SVO) | n = 50 |
| Cardioembolism and Others | n = 89 |
| Cardioembolism | n = 50 |
| TIA | n = 5 |
| not determined | n = 34 |
| Glucose and Lipids | |
| BS (MD, IQR) mg/dl | 120, 106–149 |
| HbA1c (MD, IQR) % | 5.8, 5.6–6.3 |
| T-CHO (m ± SD) mg/dl | 203.4 ± 40.2 |
| LDL-C (m ± SD) mg/dl | 121.2 ± 33.5 |
| HDL-C (MD, IQR) mg/dl | 56.1, 45.2–69.6 |
| TG (MD, IQR) mg/dl | 94.5, 68.8–134.5 |
| Saturated Fatty Acids | |
| lauric acid (LaA) (C12:0) (MD, IQR) μg/ml | 1.2, 0.7–2.3 |
| myristic acid (MyA) (C14:0) (MD, IQR) μg/ml | 18.7, 13.7–27.2 |
| palmitic acid (PA) (C16:0) (MD, IQR) μg/ml | 680.7, 593.6–783.1 |
| stearic acid StA (C18:0) (MD, IQR) μg/ml | 203.3, 175.4–233.3 |
| LaA (C12:0) (MD, IQR) % | 0.04, 0.03–0.07 |
| MyA (C14:0) (MD, IQR) % | 0.64, 0.51–0.88 |
| PA (C16:0) (m ± SD) % | 23.7 ± 1.5 |
| StA (C18:0) (m ± SD) % | 7.0 ± 0.8 |
| n-9 Monounsaturated Fatty Acid | |
| oleic acid (OlA) (C18:1) (MD, IQR) μg/ml | 602.5, 515.8–717.4 |
| OlA (C18:1) (m ± SD) % | 21.3 ± 2.5 |
| n-6 Polyunsaturated Fatty Acids | |
| linoleic acid (LiA) (C18:2) (MD, IQR) μg/ml | 795.2, 658.2–928.3 |
| dihomogammalinolenic acid (DGLA) (C20:3) (MD, IQR) μg/ml | 28.1, 21.6–36.4 |
| arachidonic acid (AA) (C20:4) (MD, IQR) μg/ml | 146.1, 122.1–169.9 |
| LiA (C18:2) (m ± SD) % | 27.1 ± 3.4 |
| DGLA (C20:3) (m ± SD) % | 0.99 ± 0.27 |
| AA (C20:4) (m ± SD) % | 5.1 ± 1.1 |
| n-3 Polyunsaturated Fatty Acids | |
| Alpha-linolenic acid (AlA) (C18:3) (MD, IQR) μg/ml | 21.3, 15.9–29.3 |
| eicosapentaenoic acid (EPA) (C20:5) (MD, IQR) μg/ml | 62.2, 45.7–92.5 |
| docosahexaenoic acid (DHA) (C22:6) (m ± SD) μg/ml | 136.9 ± 43.2 |
| AlA (C18:3) (MD, IQR) % | 0.72, 0.6–0.96 |
| EPA (C20:5) (MD, IQR) % | 2.2, 1.5–3.23 |
| DHA (C22:6) (m ± SD) % | 4.7 ± 1.4 |
| EPA / AA ratio (MD, IQR) | 0.45, 0.32–0.6 |
| n-6 / n-3 ratio (MD, IQR) | 4.25, 3.38–5.2 |
BMI Body mass index, BS Blood sugar, T-CHO Total cholesterol, TG Triglyceride
LDL-C Low density lipoprotein cholesterol, HDL-C High density lipoprotein cholesterol
m Mean, SD Standard deviation, MD Median, IQR Interquartile range
min Minimum, max Maximum, MBP Mean blood pressure
%: weight percent of fatty acids
n-6: n-6 polyunsaturated fatty acids
n-3: n-3 polyunsaturated fatty acids